| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Medication Errors | 29 | 2022 | 784 | 5.200 |
Why?
|
| Medical Order Entry Systems | 23 | 2022 | 523 | 4.660 |
Why?
|
| Diagnostic Errors | 18 | 2022 | 1276 | 3.770 |
Why?
|
| Drug Prescriptions | 20 | 2023 | 1662 | 3.300 |
Why?
|
| Malpractice | 8 | 2022 | 561 | 3.070 |
Why?
|
| Ambulatory Care | 14 | 2023 | 2778 | 2.730 |
Why?
|
| Primary Health Care | 28 | 2024 | 4736 | 2.440 |
Why?
|
| Electronic Prescribing | 7 | 2019 | 115 | 1.980 |
Why?
|
| Delayed Diagnosis | 5 | 2020 | 452 | 1.620 |
Why?
|
| Physicians, Primary Care | 5 | 2024 | 622 | 1.590 |
Why?
|
| Physicians | 15 | 2023 | 4591 | 1.500 |
Why?
|
| Burnout, Professional | 5 | 2024 | 710 | 1.500 |
Why?
|
| Continuity of Patient Care | 7 | 2021 | 1075 | 1.210 |
Why?
|
| Medical Errors | 11 | 2022 | 1258 | 1.150 |
Why?
|
| Ambulatory Care Facilities | 4 | 2021 | 937 | 1.140 |
Why?
|
| Diagnostic Tests, Routine | 6 | 2024 | 788 | 1.100 |
Why?
|
| Communication | 15 | 2022 | 3908 | 1.080 |
Why?
|
| Professional Role | 4 | 2023 | 314 | 1.080 |
Why?
|
| Pharmaceutical Preparations | 8 | 2022 | 1084 | 1.010 |
Why?
|
| Electronic Health Records | 19 | 2024 | 4863 | 0.970 |
Why?
|
| Decision Support Systems, Clinical | 8 | 2022 | 1176 | 0.910 |
Why?
|
| Medical Informatics | 4 | 2023 | 743 | 0.880 |
Why?
|
| Medication Systems, Hospital | 5 | 2019 | 154 | 0.870 |
Why?
|
| Pharmacists | 4 | 2023 | 261 | 0.860 |
Why?
|
| Insurance Claim Reporting | 2 | 2014 | 166 | 0.860 |
Why?
|
| Quality Assurance, Health Care | 9 | 2015 | 2170 | 0.850 |
Why?
|
| Pharmacy and Therapeutics Committee | 3 | 2019 | 9 | 0.850 |
Why?
|
| Quality of Health Care | 15 | 2022 | 4305 | 0.800 |
Why?
|
| Respiratory Care Units | 1 | 2021 | 10 | 0.780 |
Why?
|
| Safety Management | 7 | 2020 | 764 | 0.740 |
Why?
|
| Patient-Centered Care | 6 | 2018 | 1447 | 0.700 |
Why?
|
| Diagnostic Techniques and Procedures | 3 | 2018 | 216 | 0.660 |
Why?
|
| Telephone | 5 | 2014 | 627 | 0.650 |
Why?
|
| Physician-Patient Relations | 8 | 2018 | 3270 | 0.650 |
Why?
|
| Humans | 164 | 2024 | 765926 | 0.640 |
Why?
|
| Pneumonia, Viral | 3 | 2021 | 3231 | 0.620 |
Why?
|
| Appointments and Schedules | 2 | 2021 | 441 | 0.600 |
Why?
|
| Decision Making | 5 | 2019 | 3955 | 0.590 |
Why?
|
| Knowledge Bases | 1 | 2018 | 96 | 0.580 |
Why?
|
| Formularies as Topic | 2 | 2021 | 93 | 0.570 |
Why?
|
| Medical Record Linkage | 3 | 2005 | 286 | 0.560 |
Why?
|
| Crying | 1 | 2017 | 37 | 0.540 |
Why?
|
| Hospitals, Public | 5 | 2011 | 205 | 0.540 |
Why?
|
| Disease | 1 | 2022 | 674 | 0.520 |
Why?
|
| Terminology as Topic | 3 | 2018 | 1536 | 0.520 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2023 | 1127 | 0.520 |
Why?
|
| Memory, Short-Term | 1 | 2022 | 1002 | 0.500 |
Why?
|
| Awards and Prizes | 1 | 2020 | 364 | 0.500 |
Why?
|
| Patient Advocacy | 2 | 2015 | 361 | 0.500 |
Why?
|
| Inappropriate Prescribing | 2 | 2016 | 211 | 0.500 |
Why?
|
| Colonoscopy | 1 | 2023 | 1408 | 0.490 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 746 | 0.490 |
Why?
|
| Staff Development | 1 | 2017 | 231 | 0.480 |
Why?
|
| Speech Recognition Software | 3 | 2014 | 74 | 0.480 |
Why?
|
| Social Justice | 2 | 2014 | 484 | 0.480 |
Why?
|
| Documentation | 8 | 2022 | 911 | 0.470 |
Why?
|
| Outpatients | 3 | 2018 | 1595 | 0.470 |
Why?
|
| Epidemics | 1 | 2020 | 514 | 0.460 |
Why?
|
| Health Personnel | 3 | 2023 | 3385 | 0.460 |
Why?
|
| Education, Medical | 4 | 2018 | 1744 | 0.450 |
Why?
|
| Risk Management | 1 | 2017 | 558 | 0.440 |
Why?
|
| Referral and Consultation | 9 | 2023 | 3615 | 0.440 |
Why?
|
| Analgesics, Opioid | 6 | 2024 | 3834 | 0.430 |
Why?
|
| Altruism | 1 | 2015 | 210 | 0.420 |
Why?
|
| Ethics, Professional | 1 | 2013 | 100 | 0.420 |
Why?
|
| Diet, Reducing | 1 | 2016 | 487 | 0.420 |
Why?
|
| Anti-Obesity Agents | 1 | 2016 | 240 | 0.410 |
Why?
|
| Drug Therapy | 2 | 2009 | 504 | 0.410 |
Why?
|
| Professional-Patient Relations | 2 | 2015 | 723 | 0.410 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 3109 | 0.410 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 4 | 2024 | 497 | 0.390 |
Why?
|
| Patient Care Team | 7 | 2022 | 2515 | 0.390 |
Why?
|
| Delivery of Health Care | 7 | 2022 | 5364 | 0.380 |
Why?
|
| Attitude of Health Personnel | 7 | 2019 | 3928 | 0.380 |
Why?
|
| Social Responsibility | 1 | 2014 | 382 | 0.380 |
Why?
|
| Software | 3 | 2023 | 4462 | 0.380 |
Why?
|
| Workflow | 5 | 2021 | 859 | 0.370 |
Why?
|
| Mass Screening | 3 | 2018 | 5449 | 0.360 |
Why?
|
| Uncertainty | 4 | 2023 | 763 | 0.360 |
Why?
|
| Organizational Policy | 2 | 2010 | 434 | 0.360 |
Why?
|
| Clinical Pharmacy Information Systems | 2 | 2003 | 102 | 0.350 |
Why?
|
| Counseling | 1 | 2018 | 1551 | 0.350 |
Why?
|
| Crowding | 1 | 2011 | 142 | 0.350 |
Why?
|
| Prescription Drugs | 3 | 2012 | 634 | 0.340 |
Why?
|
| Opioid-Related Disorders | 2 | 2022 | 2177 | 0.340 |
Why?
|
| United States | 30 | 2022 | 72909 | 0.340 |
Why?
|
| Pharmacies | 4 | 2018 | 171 | 0.340 |
Why?
|
| Drug Implants | 1 | 2010 | 230 | 0.340 |
Why?
|
| Health Services Misuse | 1 | 2011 | 245 | 0.330 |
Why?
|
| Disease Management | 1 | 2020 | 2530 | 0.330 |
Why?
|
| Adenoma, Oxyphilic | 1 | 2011 | 150 | 0.330 |
Why?
|
| Quality Improvement | 5 | 2019 | 3847 | 0.330 |
Why?
|
| Education, Pharmacy | 1 | 2009 | 38 | 0.320 |
Why?
|
| Massachusetts | 11 | 2017 | 8882 | 0.310 |
Why?
|
| Drug Labeling | 2 | 2017 | 251 | 0.310 |
Why?
|
| Data Mining | 1 | 2013 | 559 | 0.300 |
Why?
|
| Radiology | 1 | 2022 | 2105 | 0.300 |
Why?
|
| Diagnostic Services | 2 | 2021 | 33 | 0.300 |
Why?
|
| Marketing | 1 | 2010 | 225 | 0.300 |
Why?
|
| Emergency Service, Hospital | 5 | 2018 | 7871 | 0.300 |
Why?
|
| Checklist | 2 | 2012 | 837 | 0.290 |
Why?
|
| Health Care Surveys | 7 | 2017 | 2426 | 0.290 |
Why?
|
| Patient Care | 3 | 2014 | 628 | 0.290 |
Why?
|
| Retrospective Studies | 25 | 2024 | 81537 | 0.280 |
Why?
|
| Organizational Innovation | 3 | 2019 | 540 | 0.280 |
Why?
|
| Hyperkalemia | 3 | 2016 | 233 | 0.280 |
Why?
|
| Reimbursement, Incentive | 1 | 2012 | 541 | 0.280 |
Why?
|
| Weight Loss | 2 | 2016 | 2710 | 0.280 |
Why?
|
| Incidental Findings | 2 | 2013 | 698 | 0.280 |
Why?
|
| Models, Theoretical | 1 | 2019 | 3560 | 0.270 |
Why?
|
| Chronic Disease | 3 | 2020 | 9351 | 0.270 |
Why?
|
| Drug Interactions | 5 | 2018 | 1416 | 0.270 |
Why?
|
| Pandemics | 3 | 2021 | 8721 | 0.270 |
Why?
|
| Patient Preference | 1 | 2014 | 947 | 0.260 |
Why?
|
| Financing, Personal | 2 | 2013 | 310 | 0.260 |
Why?
|
| Humanism | 2 | 2019 | 84 | 0.260 |
Why?
|
| Health Care Reform | 5 | 2022 | 1257 | 0.260 |
Why?
|
| Tablets | 1 | 2006 | 149 | 0.250 |
Why?
|
| Adult | 31 | 2024 | 223088 | 0.250 |
Why?
|
| Colorectal Neoplasms | 2 | 2017 | 6958 | 0.250 |
Why?
|
| Conflict of Interest | 1 | 2010 | 556 | 0.250 |
Why?
|
| Hospital Administration | 2 | 2017 | 351 | 0.240 |
Why?
|
| Middle Aged | 35 | 2024 | 223016 | 0.240 |
Why?
|
| Drug Monitoring | 4 | 2016 | 960 | 0.240 |
Why?
|
| Hormone Replacement Therapy | 1 | 2010 | 752 | 0.240 |
Why?
|
| Emergency Medicine | 3 | 2015 | 1222 | 0.230 |
Why?
|
| Clinical Laboratory Information Systems | 2 | 2003 | 108 | 0.230 |
Why?
|
| Qualitative Research | 5 | 2023 | 3136 | 0.230 |
Why?
|
| Substance Abuse Detection | 3 | 2024 | 301 | 0.230 |
Why?
|
| Thyroid Function Tests | 1 | 2005 | 289 | 0.230 |
Why?
|
| Male | 44 | 2024 | 363815 | 0.220 |
Why?
|
| Health Policy | 4 | 2018 | 2699 | 0.220 |
Why?
|
| Dyspnea | 1 | 2012 | 1351 | 0.220 |
Why?
|
| Female | 45 | 2024 | 396141 | 0.220 |
Why?
|
| Laboratories | 3 | 2021 | 463 | 0.220 |
Why?
|
| Estrogens | 1 | 2010 | 1528 | 0.220 |
Why?
|
| Clinical Competence | 3 | 2009 | 4855 | 0.220 |
Why?
|
| Hospitals, Proprietary | 2 | 2000 | 37 | 0.210 |
Why?
|
| Gemfibrozil | 1 | 2002 | 30 | 0.210 |
Why?
|
| Health Services Accessibility | 5 | 2011 | 5509 | 0.210 |
Why?
|
| Pharmacy Service, Hospital | 2 | 2010 | 134 | 0.210 |
Why?
|
| Information Dissemination | 2 | 2013 | 1142 | 0.210 |
Why?
|
| American Public Health Association | 1 | 2022 | 1 | 0.200 |
Why?
|
| Early Detection of Cancer | 1 | 2017 | 3238 | 0.200 |
Why?
|
| Emergency Medical Services | 1 | 2014 | 1937 | 0.200 |
Why?
|
| Internal Medicine | 1 | 2009 | 1064 | 0.200 |
Why?
|
| Diagnosis, Differential | 3 | 2023 | 12973 | 0.190 |
Why?
|
| Hospitals, Community | 3 | 2013 | 363 | 0.190 |
Why?
|
| Feedback | 2 | 2020 | 796 | 0.190 |
Why?
|
| Single-Payer System | 1 | 2022 | 35 | 0.190 |
Why?
|
| Internship and Residency | 5 | 2023 | 5945 | 0.190 |
Why?
|
| Thyroxine | 1 | 2005 | 665 | 0.190 |
Why?
|
| Patient Education as Topic | 3 | 2018 | 2331 | 0.180 |
Why?
|
| Public Health | 1 | 2014 | 2680 | 0.180 |
Why?
|
| Social Identification | 1 | 2021 | 108 | 0.180 |
Why?
|
| Truth Disclosure | 1 | 2005 | 433 | 0.180 |
Why?
|
| Systems Analysis | 1 | 2021 | 168 | 0.180 |
Why?
|
| Publications | 1 | 2023 | 195 | 0.180 |
Why?
|
| Medically Underserved Area | 1 | 2003 | 267 | 0.170 |
Why?
|
| Medical Records Systems, Computerized | 6 | 2019 | 1195 | 0.170 |
Why?
|
| Patient Participation | 3 | 2021 | 1447 | 0.170 |
Why?
|
| Chromatography, Liquid | 2 | 2021 | 991 | 0.170 |
Why?
|
| Health Services for the Aged | 1 | 2002 | 264 | 0.170 |
Why?
|
| Hypothyroidism | 1 | 2005 | 665 | 0.170 |
Why?
|
| Hospitals, Voluntary | 1 | 2000 | 39 | 0.170 |
Why?
|
| False Positive Reactions | 2 | 2020 | 956 | 0.170 |
Why?
|
| Computers | 1 | 2002 | 588 | 0.170 |
Why?
|
| Muscle Weakness | 1 | 2002 | 412 | 0.170 |
Why?
|
| Cooperative Behavior | 5 | 2017 | 1512 | 0.160 |
Why?
|
| False Negative Reactions | 1 | 2020 | 570 | 0.160 |
Why?
|
| Medical Audit | 2 | 2017 | 454 | 0.160 |
Why?
|
| Hospitalists | 1 | 2003 | 297 | 0.160 |
Why?
|
| User-Computer Interface | 3 | 2022 | 1404 | 0.160 |
Why?
|
| Community Health Centers | 1 | 2003 | 469 | 0.160 |
Why?
|
| Pharmacy | 1 | 2000 | 92 | 0.160 |
Why?
|
| Absorptiometry, Photon | 1 | 2005 | 1707 | 0.160 |
Why?
|
| Urinalysis | 1 | 2021 | 369 | 0.150 |
Why?
|
| Creatinine | 1 | 2024 | 1916 | 0.150 |
Why?
|
| Anthropology, Cultural | 1 | 2019 | 103 | 0.150 |
Why?
|
| Organizational Case Studies | 3 | 2017 | 301 | 0.150 |
Why?
|
| Patient Simulation | 2 | 2013 | 301 | 0.150 |
Why?
|
| Hospitals, Teaching | 3 | 2015 | 1156 | 0.150 |
Why?
|
| Aged | 21 | 2024 | 171163 | 0.150 |
Why?
|
| Hypolipidemic Agents | 1 | 2002 | 609 | 0.150 |
Why?
|
| Insurance, Health | 2 | 2008 | 2520 | 0.150 |
Why?
|
| Leadership | 2 | 2017 | 1393 | 0.140 |
Why?
|
| Drug Utilization | 2 | 2016 | 1187 | 0.140 |
Why?
|
| Ecosystem | 1 | 2022 | 489 | 0.140 |
Why?
|
| Forecasting | 3 | 2023 | 2936 | 0.140 |
Why?
|
| Insurance Carriers | 2 | 2022 | 159 | 0.140 |
Why?
|
| Patient Identification Systems | 1 | 2017 | 75 | 0.140 |
Why?
|
| Interprofessional Relations | 2 | 2015 | 998 | 0.140 |
Why?
|
| United States Agency for Healthcare Research and Quality | 1 | 2016 | 85 | 0.140 |
Why?
|
| Medication Adherence | 3 | 2018 | 2190 | 0.130 |
Why?
|
| Cation Exchange Resins | 1 | 2016 | 19 | 0.130 |
Why?
|
| Pyridines | 2 | 2012 | 2885 | 0.130 |
Why?
|
| Potassium | 1 | 2000 | 1312 | 0.130 |
Why?
|
| Medication Reconciliation | 1 | 2018 | 153 | 0.130 |
Why?
|
| Polystyrenes | 1 | 2016 | 102 | 0.130 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2017 | 4055 | 0.130 |
Why?
|
| Self Report | 2 | 2019 | 3768 | 0.120 |
Why?
|
| Osteoporosis | 1 | 2005 | 1582 | 0.120 |
Why?
|
| Patient Satisfaction | 3 | 2014 | 3477 | 0.120 |
Why?
|
| Telemedicine | 2 | 2023 | 3108 | 0.120 |
Why?
|
| Pain | 2 | 2016 | 5077 | 0.120 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2017 | 391 | 0.120 |
Why?
|
| Time Factors | 4 | 2023 | 40097 | 0.120 |
Why?
|
| Access to Information | 1 | 2017 | 317 | 0.110 |
Why?
|
| Neoplasms | 3 | 2024 | 22340 | 0.110 |
Why?
|
| National Health Insurance, United States | 1 | 1994 | 100 | 0.110 |
Why?
|
| Kidney Neoplasms | 1 | 2011 | 4278 | 0.110 |
Why?
|
| Academic Medical Centers | 6 | 2023 | 2782 | 0.110 |
Why?
|
| Obesity | 1 | 2016 | 13082 | 0.110 |
Why?
|
| Education, Medical, Continuing | 1 | 2019 | 829 | 0.110 |
Why?
|
| Feedback, Psychological | 1 | 2014 | 97 | 0.110 |
Why?
|
| Administrative Personnel | 1 | 2015 | 186 | 0.110 |
Why?
|
| Databases, Factual | 4 | 2019 | 8060 | 0.110 |
Why?
|
| Reference Standards | 1 | 2017 | 1011 | 0.110 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2019 | 1194 | 0.110 |
Why?
|
| Feasibility Studies | 1 | 2024 | 5300 | 0.110 |
Why?
|
| Forms and Records Control | 1 | 1994 | 158 | 0.110 |
Why?
|
| Models, Organizational | 2 | 2011 | 548 | 0.100 |
Why?
|
| Data Collection | 4 | 2022 | 3318 | 0.100 |
Why?
|
| Chicago | 5 | 2019 | 255 | 0.100 |
Why?
|
| Personnel, Hospital | 1 | 2015 | 285 | 0.100 |
Why?
|
| Total Quality Management | 1 | 1994 | 264 | 0.100 |
Why?
|
| Dermatology | 1 | 2022 | 905 | 0.100 |
Why?
|
| Boston | 2 | 2023 | 9334 | 0.100 |
Why?
|
| Interdisciplinary Communication | 2 | 2015 | 931 | 0.100 |
Why?
|
| Drugs, Generic | 1 | 2017 | 457 | 0.100 |
Why?
|
| Acute Kidney Injury | 1 | 2024 | 1943 | 0.100 |
Why?
|
| Cognition | 2 | 2022 | 7043 | 0.100 |
Why?
|
| Gentian Violet | 1 | 1991 | 25 | 0.100 |
Why?
|
| Bone Density | 1 | 2005 | 3491 | 0.100 |
Why?
|
| Product Labeling | 1 | 2012 | 75 | 0.100 |
Why?
|
| Phenazines | 1 | 1991 | 53 | 0.100 |
Why?
|
| Diagnosis-Related Groups | 2 | 2014 | 445 | 0.090 |
Why?
|
| Inpatients | 3 | 2022 | 2563 | 0.090 |
Why?
|
| Ambulatory Care Information Systems | 1 | 2011 | 89 | 0.090 |
Why?
|
| Delivery of Health Care, Integrated | 2 | 2019 | 949 | 0.090 |
Why?
|
| Insurance Coverage | 1 | 2002 | 1945 | 0.090 |
Why?
|
| Job Satisfaction | 1 | 2015 | 548 | 0.090 |
Why?
|
| Theophylline | 1 | 1991 | 132 | 0.090 |
Why?
|
| Pilot Projects | 4 | 2014 | 8724 | 0.090 |
Why?
|
| Systems Integration | 3 | 2013 | 425 | 0.090 |
Why?
|
| Prostatic Neoplasms | 1 | 2013 | 11090 | 0.090 |
Why?
|
| Program Development | 1 | 2017 | 1297 | 0.090 |
Why?
|
| Regional Medical Programs | 1 | 2011 | 64 | 0.090 |
Why?
|
| Health Services Research | 3 | 2022 | 1811 | 0.090 |
Why?
|
| Hospitals | 3 | 2011 | 3886 | 0.090 |
Why?
|
| Quinoxalines | 1 | 2012 | 296 | 0.090 |
Why?
|
| Nicotinic Agonists | 1 | 2012 | 265 | 0.090 |
Why?
|
| Benzazepines | 1 | 2012 | 308 | 0.090 |
Why?
|
| Natural Language Processing | 1 | 2019 | 1198 | 0.090 |
Why?
|
| Canada | 1 | 2015 | 2120 | 0.090 |
Why?
|
| Students, Medical | 2 | 2018 | 1962 | 0.090 |
Why?
|
| Remote Consultation | 1 | 2013 | 241 | 0.090 |
Why?
|
| Utah | 2 | 2000 | 130 | 0.080 |
Why?
|
| Colorado | 2 | 2000 | 167 | 0.080 |
Why?
|
| Needs Assessment | 1 | 2015 | 1140 | 0.080 |
Why?
|
| Physician's Role | 2 | 2015 | 925 | 0.080 |
Why?
|
| Prospective Studies | 5 | 2023 | 54807 | 0.080 |
Why?
|
| Socioeconomic Factors | 2 | 2010 | 7842 | 0.080 |
Why?
|
| Sputum | 1 | 1991 | 513 | 0.080 |
Why?
|
| Medicare | 2 | 2008 | 6815 | 0.080 |
Why?
|
| Hospitalization | 4 | 2016 | 10810 | 0.080 |
Why?
|
| United States Food and Drug Administration | 1 | 2017 | 1673 | 0.080 |
Why?
|
| Reminder Systems | 2 | 2018 | 388 | 0.080 |
Why?
|
| Young Adult | 9 | 2018 | 59857 | 0.070 |
Why?
|
| Diagnostic Imaging | 1 | 2022 | 3530 | 0.070 |
Why?
|
| Reproducibility of Results | 5 | 2022 | 20133 | 0.070 |
Why?
|
| Spinal Stenosis | 1 | 2011 | 259 | 0.070 |
Why?
|
| Algorithms | 3 | 2019 | 14064 | 0.070 |
Why?
|
| Hypnotics and Sedatives | 2 | 2013 | 1192 | 0.070 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2002 | 3249 | 0.070 |
Why?
|
| Iatrogenic Disease | 1 | 1991 | 551 | 0.070 |
Why?
|
| Renal Insufficiency | 1 | 2013 | 810 | 0.070 |
Why?
|
| Hospital Information Systems | 1 | 1990 | 395 | 0.070 |
Why?
|
| Professional Practice | 1 | 2009 | 314 | 0.070 |
Why?
|
| Medical Records | 2 | 1990 | 1408 | 0.070 |
Why?
|
| Staphylococcal Infections | 2 | 2010 | 1392 | 0.070 |
Why?
|
| Staining and Labeling | 1 | 1991 | 1072 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 3 | 2022 | 7473 | 0.070 |
Why?
|
| Sensitivity and Specificity | 2 | 2020 | 14643 | 0.070 |
Why?
|
| Cross-Sectional Studies | 5 | 2015 | 26282 | 0.070 |
Why?
|
| Unnecessary Procedures | 1 | 2010 | 412 | 0.070 |
Why?
|
| Medically Uninsured | 2 | 2003 | 838 | 0.070 |
Why?
|
| Appendectomy | 1 | 2010 | 445 | 0.070 |
Why?
|
| Aged, 80 and over | 7 | 2018 | 59496 | 0.070 |
Why?
|
| Evaluation Studies as Topic | 2 | 2001 | 1607 | 0.060 |
Why?
|
| Naproxen | 1 | 2006 | 99 | 0.060 |
Why?
|
| Curriculum | 1 | 2019 | 3784 | 0.060 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 1990 | 463 | 0.060 |
Why?
|
| Drug Costs | 1 | 2013 | 1194 | 0.060 |
Why?
|
| Cohort Studies | 3 | 2018 | 41680 | 0.060 |
Why?
|
| Lorazepam | 1 | 2006 | 155 | 0.060 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2010 | 698 | 0.060 |
Why?
|
| Research | 1 | 2013 | 1974 | 0.060 |
Why?
|
| Joint Commission on Accreditation of Healthcare Organizations | 1 | 2005 | 91 | 0.060 |
Why?
|
| Vibrio cholerae | 2 | 2001 | 793 | 0.060 |
Why?
|
| Cholera | 3 | 2001 | 754 | 0.060 |
Why?
|
| Combined Modality Therapy | 1 | 2016 | 8522 | 0.060 |
Why?
|
| Population Surveillance | 1 | 2015 | 2596 | 0.060 |
Why?
|
| Medical History Taking | 1 | 2008 | 779 | 0.060 |
Why?
|
| Mammography | 1 | 2015 | 2424 | 0.060 |
Why?
|
| Blood Specimen Collection | 1 | 2005 | 238 | 0.060 |
Why?
|
| Drug Industry | 1 | 2010 | 791 | 0.060 |
Why?
|
| Health Services Needs and Demand | 1 | 2011 | 1404 | 0.050 |
Why?
|
| Simvastatin | 1 | 2006 | 345 | 0.050 |
Why?
|
| Vancomycin | 2 | 2010 | 504 | 0.050 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2010 | 704 | 0.050 |
Why?
|
| Appendicitis | 1 | 2010 | 680 | 0.050 |
Why?
|
| Observer Variation | 1 | 2009 | 2611 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2021 | 22228 | 0.050 |
Why?
|
| Occult Blood | 1 | 2004 | 199 | 0.050 |
Why?
|
| Medical Oncology | 1 | 2015 | 2339 | 0.050 |
Why?
|
| Skin Neoplasms | 1 | 2022 | 5836 | 0.050 |
Why?
|
| Follow-Up Studies | 4 | 2019 | 39228 | 0.050 |
Why?
|
| Blood | 1 | 2005 | 597 | 0.050 |
Why?
|
| Anecdotes as Topic | 1 | 2002 | 56 | 0.050 |
Why?
|
| Tape Recording | 1 | 2022 | 78 | 0.050 |
Why?
|
| Income Tax | 1 | 2002 | 25 | 0.050 |
Why?
|
| Government Agencies | 1 | 2002 | 161 | 0.050 |
Why?
|
| Information Systems | 2 | 2016 | 400 | 0.050 |
Why?
|
| Medicaid | 2 | 2008 | 2833 | 0.050 |
Why?
|
| Capitation Fee | 1 | 2001 | 115 | 0.050 |
Why?
|
| Adolescent | 9 | 2018 | 88811 | 0.050 |
Why?
|
| Cancer Care Facilities | 1 | 2024 | 427 | 0.050 |
Why?
|
| Vancomycin Resistance | 1 | 2001 | 125 | 0.040 |
Why?
|
| Creatine Kinase | 1 | 2002 | 682 | 0.040 |
Why?
|
| Prevalence | 2 | 2015 | 15828 | 0.040 |
Why?
|
| Cholera Vaccines | 2 | 2001 | 264 | 0.040 |
Why?
|
| Autopsy | 1 | 1984 | 1011 | 0.040 |
Why?
|
| Nursing Service, Hospital | 1 | 2000 | 17 | 0.040 |
Why?
|
| Lebanon | 1 | 2001 | 246 | 0.040 |
Why?
|
| Administration, Oral | 2 | 2006 | 4016 | 0.040 |
Why?
|
| Hospitals, County | 1 | 1980 | 18 | 0.040 |
Why?
|
| Patient Discharge | 2 | 1990 | 3460 | 0.040 |
Why?
|
| Reading | 1 | 2024 | 540 | 0.040 |
Why?
|
| Veterans Health | 1 | 2022 | 216 | 0.040 |
Why?
|
| Treatment Refusal | 1 | 2003 | 433 | 0.040 |
Why?
|
| Health Priorities | 1 | 2003 | 382 | 0.040 |
Why?
|
| Exercise | 1 | 2016 | 5936 | 0.040 |
Why?
|
| Antibodies, Bacterial | 3 | 2001 | 1473 | 0.040 |
Why?
|
| Health Care Sector | 1 | 2001 | 196 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2013 | 20690 | 0.040 |
Why?
|
| Academies and Institutes | 1 | 2001 | 326 | 0.040 |
Why?
|
| Eligibility Determination | 1 | 2002 | 422 | 0.040 |
Why?
|
| Incidence | 2 | 2024 | 21513 | 0.040 |
Why?
|
| Heart Failure | 1 | 2003 | 11837 | 0.040 |
Why?
|
| Interdepartmental Relations | 1 | 1998 | 14 | 0.040 |
Why?
|
| Drug Resistance, Microbial | 1 | 2001 | 832 | 0.040 |
Why?
|
| Health Expenditures | 1 | 2011 | 2388 | 0.040 |
Why?
|
| Drug Information Services | 1 | 1998 | 51 | 0.040 |
Why?
|
| Risk Assessment | 4 | 2016 | 24275 | 0.040 |
Why?
|
| Midwestern United States | 1 | 2017 | 70 | 0.040 |
Why?
|
| Risk Adjustment | 1 | 2021 | 596 | 0.040 |
Why?
|
| Ownership | 1 | 2000 | 338 | 0.030 |
Why?
|
| Communicable Diseases | 1 | 2005 | 873 | 0.030 |
Why?
|
| Guideline Adherence | 2 | 2011 | 2234 | 0.030 |
Why?
|
| Proton Pump Inhibitors | 1 | 2022 | 551 | 0.030 |
Why?
|
| Computer Systems | 1 | 1998 | 466 | 0.030 |
Why?
|
| Fee-for-Service Plans | 1 | 2001 | 713 | 0.030 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 1980 | 388 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2021 | 1186 | 0.030 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2011 | 3183 | 0.030 |
Why?
|
| Patient Admission | 1 | 2003 | 1365 | 0.030 |
Why?
|
| Benzodiazepines | 1 | 2022 | 1136 | 0.030 |
Why?
|
| Glomerular Filtration Rate | 1 | 2024 | 2233 | 0.030 |
Why?
|
| Logistic Models | 3 | 2017 | 13273 | 0.030 |
Why?
|
| Data Interpretation, Statistical | 1 | 2005 | 2688 | 0.030 |
Why?
|
| Phonetics | 1 | 2016 | 207 | 0.030 |
Why?
|
| Regression Analysis | 2 | 2016 | 6321 | 0.030 |
Why?
|
| Infant | 1 | 2017 | 36426 | 0.030 |
Why?
|
| Cost Savings | 1 | 2019 | 900 | 0.030 |
Why?
|
| Management Quality Circles | 1 | 1994 | 20 | 0.030 |
Why?
|
| Australia | 1 | 2017 | 1260 | 0.030 |
Why?
|
| Clinical Audit | 1 | 2013 | 29 | 0.030 |
Why?
|
| Workload | 1 | 2019 | 848 | 0.030 |
Why?
|
| Cholecystitis, Acute | 1 | 2013 | 81 | 0.030 |
Why?
|
| History, 20th Century | 1 | 2001 | 2760 | 0.030 |
Why?
|
| Alabama | 1 | 2013 | 111 | 0.030 |
Why?
|
| Income | 1 | 2001 | 1874 | 0.030 |
Why?
|
| Colonic Neoplasms | 1 | 2004 | 2530 | 0.020 |
Why?
|
| Pelvic Neoplasms | 1 | 2013 | 248 | 0.020 |
Why?
|
| Narcotics | 1 | 2013 | 333 | 0.020 |
Why?
|
| Auditory Perception | 1 | 2016 | 586 | 0.020 |
Why?
|
| Poverty | 1 | 2003 | 2714 | 0.020 |
Why?
|
| Attitude to Computers | 1 | 2011 | 196 | 0.020 |
Why?
|
| World Health Organization | 1 | 2016 | 1326 | 0.020 |
Why?
|
| Daptomycin | 1 | 2010 | 71 | 0.020 |
Why?
|
| Education, Medical, Graduate | 1 | 2022 | 2419 | 0.020 |
Why?
|
| Drug Therapy, Computer-Assisted | 1 | 2011 | 198 | 0.020 |
Why?
|
| Oxazolidinones | 1 | 2010 | 99 | 0.020 |
Why?
|
| Angioedema | 1 | 2011 | 184 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2016 | 2717 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2017 | 2740 | 0.020 |
Why?
|
| Poisoning | 1 | 1991 | 254 | 0.020 |
Why?
|
| Perception | 1 | 2016 | 1204 | 0.020 |
Why?
|
| Interinstitutional Relations | 1 | 2011 | 235 | 0.020 |
Why?
|
| Patient Care Planning | 1 | 2015 | 903 | 0.020 |
Why?
|
| Patient Isolation | 1 | 2010 | 101 | 0.020 |
Why?
|
| Freezing | 2 | 2001 | 310 | 0.020 |
Why?
|
| Minocycline | 1 | 2010 | 168 | 0.020 |
Why?
|
| Palliative Care | 1 | 2024 | 3640 | 0.020 |
Why?
|
| Child | 1 | 2017 | 80568 | 0.020 |
Why?
|
| Acetamides | 1 | 2010 | 260 | 0.020 |
Why?
|
| Hypotension, Orthostatic | 1 | 2011 | 258 | 0.020 |
Why?
|
| Calcium Channel Blockers | 1 | 2011 | 685 | 0.020 |
Why?
|
| Longitudinal Studies | 2 | 2017 | 14745 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 1989 | 11508 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2015 | 21069 | 0.020 |
Why?
|
| Risk Factors | 2 | 2011 | 74850 | 0.020 |
Why?
|
| Abdominal Pain | 1 | 2013 | 1069 | 0.020 |
Why?
|
| Politics | 1 | 1994 | 821 | 0.020 |
Why?
|
| Delphi Technique | 1 | 2011 | 893 | 0.020 |
Why?
|
| Commerce | 1 | 2012 | 612 | 0.020 |
Why?
|
| Memory | 1 | 2016 | 2191 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2015 | 15401 | 0.020 |
Why?
|
| Community Health Services | 1 | 2011 | 657 | 0.020 |
Why?
|
| Patients | 1 | 2012 | 908 | 0.020 |
Why?
|
| Diabetes Mellitus | 2 | 2014 | 5889 | 0.020 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2011 | 1513 | 0.010 |
Why?
|
| Clinical Protocols | 1 | 2010 | 1435 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2001 | 7423 | 0.010 |
Why?
|
| Guidelines as Topic | 1 | 2010 | 1394 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2011 | 36547 | 0.010 |
Why?
|
| Accidental Falls | 1 | 2011 | 1079 | 0.010 |
Why?
|
| Diagnosis | 1 | 1984 | 157 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2016 | 7116 | 0.010 |
Why?
|
| Hip Fractures | 1 | 2011 | 995 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2013 | 4882 | 0.010 |
Why?
|
| Infection Control | 1 | 2010 | 984 | 0.010 |
Why?
|
| Quality Control | 1 | 2005 | 835 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 1990 | 1793 | 0.010 |
Why?
|
| Databases as Topic | 1 | 2004 | 472 | 0.010 |
Why?
|
| Antihypertensive Agents | 1 | 2011 | 2028 | 0.010 |
Why?
|
| Colony Count, Microbial | 1 | 2001 | 326 | 0.010 |
Why?
|
| Serotyping | 1 | 2001 | 330 | 0.010 |
Why?
|
| Thailand | 1 | 2001 | 288 | 0.010 |
Why?
|
| Specialization | 1 | 2005 | 779 | 0.010 |
Why?
|
| Educational Measurement | 1 | 2007 | 1260 | 0.010 |
Why?
|
| Double-Blind Method | 2 | 2007 | 12417 | 0.010 |
Why?
|
| Illinois | 1 | 1980 | 120 | 0.010 |
Why?
|
| Coronary Disease | 1 | 2013 | 5919 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2011 | 12059 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 1984 | 2350 | 0.010 |
Why?
|
| Medicine | 1 | 2005 | 944 | 0.010 |
Why?
|
| Ovarian Neoplasms | 1 | 2013 | 4904 | 0.010 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2010 | 3230 | 0.010 |
Why?
|
| Cholera Toxin | 1 | 1998 | 562 | 0.010 |
Why?
|
| Feces | 1 | 2001 | 1503 | 0.010 |
Why?
|
| Research Design | 1 | 2011 | 6204 | 0.010 |
Why?
|
| Immunoglobulin A | 1 | 1998 | 992 | 0.010 |
Why?
|
| Coronary Artery Disease | 1 | 2014 | 6544 | 0.010 |
Why?
|
| Age Factors | 1 | 2010 | 18382 | 0.010 |
Why?
|
| Disease Outbreaks | 1 | 2001 | 1761 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2018 | 65194 | 0.010 |
Why?
|
| Hypertension | 1 | 2011 | 8616 | 0.010 |
Why?
|
| Vaccination | 1 | 1999 | 3430 | 0.000 |
Why?
|
| Immunoglobulin G | 1 | 1998 | 4555 | 0.000 |
Why?
|
| Models, Biological | 1 | 2001 | 9443 | 0.000 |
Why?
|